MedTrace Logo

Pharmacokinetics of THCCOOH and Its Acyl-glucuronide After Intravenous Administration of THCCOOH

NCT00176085 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2015-05-28

No results posted yet for this study

Summary

A study on the fate and elimination of 11-Nor-Delta9-carboxy-9-tetrahydrocannabinol was up to now not conducted, except of one single experiment in which (lacking) psychopharmacological activity was tested after intravenous infusion of 20 mg in a human individual. In this study, however, the authors did not trace the above questions due to analytical and methodological deficits.

Aim of the study is to determine the pharmacokinetics of THCCOOH and THCCOOH-Glu after intravenous ad-ministration of 5 mg THCCOOH in healthy individuals

Conditions

  • THCCOOH
  • Pharmacokinetics
  • Metabolism
  • Cannabis

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Gerd Mikus, MD BSc · Department of Internal Medicine VI

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-10-31
Completion
2005-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00176085 on ClinicalTrials.gov